Structural Heart

This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).

Videos | Structural Heart
VIDEO: Interventional Structural Heart Advances Are Rapidly Expanding

Juan F. Granada, M.D., CEO of the Cardiovascular Research Foundation (CRF) explains structural heart innovations and new ...

Home September 16, 2020
Home
Medtronic announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study (EFS) of the Intrepid Transcatheter Tricuspid Valve Replacement (TTVR) system. The study begins on the heels of a recent Breakthrough Device Designation issued by the FDA for the Intrepid TTVR System. The Intrepid TTVR system is an investigational device worldwide.
News | Heart Valve Technology
Medtronic Receives FDA Breakthrough Device Designation and Begins Trial for Intrepid Tricuspid Transcatheter Valve 

September 11, 2020 – Medtronic announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study ...

Home September 11, 2020
Home
An example of a 80-year-old TAVR patient planning CT scan from Northwestern Medicine's Central DuPage Hospital. This was used in a heart team meeting with the TAVR staff, including a cardiac surgeon and interventional cardiologist, to determine if this patient was eligable for TAVR, the best access routes to deliver the valve, device valve size needed, and to look for any potential anatomical issues so they can be planned for. 
News | Structural Heart
Northwestern Medicine Celebrates 2000th Transcatheter Heart Valve Procedure

September 2, 2020 — Northwestern Medicine Bluhm Cardiovascular Institute physicians recently completed their 2,000th tra ...

Home September 02, 2020
Home
Researchers 3-D Print Lifelike Heart Valve Models with embedded sensor technology
News | Medical 3-D Printing
Researchers 3-D Print Lifelike Heart Valve Models

September 2, 2020 — Patient-specific organ models are being used by the University of Minnesota to better prepare for ...

Home September 02, 2020
Home
Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and Innovation (CVCRI), explains the concpet of the Door-to-Unloading (DTU) Trial he is heading, one of several innovations at Tufts Medical Center in Boston. Kapur is also director, Acute Mechanical Circulatory Support Program; director, interventional research laboratories; director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI), Tufts Medical Center. Photo by Dave Fornell
Feature | Tufts Medical Center | Dave Fornell, Editor
Cardiovascular Innovation at Tufts Medical Center

The cardiology program at Tufts Medical Center in Boston is internationally recognized for being on the forefront of ...

Home August 21, 2020
Home
Boston Scientific recently introduced the newst iteration of LAA occluder device, the Watchman FLX. It uses small spikes to help better anchor the device and prevent embolization.
News | Left Atrial Appendage (LAA) Occluders
COVID-19 Boosts Demand for Left Atrial Appendage Closure Devices Market

August 21, 2020 — According to a report published by Research Dive, the rising number of patients suffering from atrial ...

Home August 21, 2020
Home
National Survey Of Heart Valve Patients Shows Importance Of Seeking Treatment Early
News | Heart Valve Technology
National Survey Of Heart Valve Patients Shows Importance Of Seeking Treatment Early

August 12, 2020 — A national survey conducted by the patient advocacy group Heart-Valve-Surgery.com with support by ...

Home August 12, 2020
Home
The Conformal Medical CLAAS device, a next-generation transcatheter left atrial appendage (LAA) closure occluder for patients with atrial fibrillation (AF). LAA occlusion allows AFib patients to go off of life-long anticoagulation therapy. #LAA #LAAC
News | Left Atrial Appendage (LAA) Occluders
Conformal Medical Secures $85 Million in Funding for Left Atrial Appendage Occluder Trial

August 6, 2020 – Conformal Medical Inc. announced it secured $85 million in Series C financing to support the company’s ...

Home August 06, 2020
Home
CardioMech's transcatheter chordae tendineae repair system uses a catheter to attach an anchor on the mitral valve leaflet and then attaches it via a cord to the apex of the heart.
News | Heart Valve Technology
Transcatheter Mitral Valve Repair Startup CardioMech Raised $18.5 Million

August 5, 2020 – Minneapolis-based CardioMech AS, a medical device company developing a transfemoral, transseptally ...

Home August 05, 2020
Home
Two of the top pieces of content in July included the FDA clearance for the new Watchman FLX left atrial appendage occluder (left), which includes a video interview with one of the trial investigators. COVID-19 content remained among the top content in July, and one story explained the odd pattern of cardiac cell death in COVID-19 patient autopsies. 
Feature | Dave Fornell, Editor
Most Popular Cardiology Technology Content in July 2020

August 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) mag ...

Home August 03, 2020
Home
A cardiac CT of a patient with pacemaker leads, which can be challenging to get good images due to metal artifact. This image was rendered from using Canon's AiCE AI-assisted interactive reconstruction with Global Illumination 3-D rendering from a scan on an Aquilion One Genesis SP system.
Feature | CT Angiography (CTA) | Dave Fornell, Editor
Top 9 Cardiovascular CT Studies in Past Year

There has been tremendous growth in the field of cardiovascular computed tomography (CT) in the past two decades, with ...

Home July 27, 2020
Home
Videos | Left Atrial Appendage (LAA) Occluders
VIDEO: Overview of LAA Occlusion Using the Watchman FLX

Devi G. Nair, M.D., FHRS, director of cardiac electrophysiology, St. Bernards Heart and Vascular Center, Jonesboro, Ark ...

Home July 24, 2020
Home
The U.S. Food and Drug Administration (FDA) has approved Boston Scientific's next generation Watchman FLX Left Atrial Appendage Closure (LAAC) Device.
News | Left Atrial Appendage (LAA) Occluders
FDA Clears Next-generation Watchman FLX Left Atrial Appendage Occluder

July 22, 2020 — The U.S. Food and Drug Administration (FDA) has approved Boston Scientific's next generation Watchman ...

Home July 22, 2020
Home
The Edwards Konect Resilia aortic valved conduit (AVC).
News | Heart Valve Technology
FDA Clears Edwards Konect Resilia Aortic Valved Conduit For Complex Aortic Valve Surgeries

July 15, 2020 —  The U.S. Food and Drug Administration (FDA) granted clearance for the Edwards Lifesciences Corp. Konect ...

Home July 15, 2020
Home
A comparison of the Edwards Pascal (left) and the Abbott MitraClip used for transcatheter mitral and tricuspid valve leaflet repairs. The two companies settled patent litigation regarding the devices today.
News | Structural Heart
Edwards Lifesciences and Abbott Settle Transcatheter Mitral Valve Device Patent Litigation

July 13, 2020 — Edwards Lifesciences Corp. and Abbott Vascular announced the two companies have reached an agreement to ...

Home July 13, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now